Treatment of triple negative breast cancer (TNBC): current options and future perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of triple negative breast cancer (TNBC): current options and future perspectives

Published:2010-11 Issue: Volume:36 Page:S80-S86
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

De Laurentiis M.,Cianniello D.,Caputo R.,Stanzione B,Arpino G.,Cinieri S.,Lorusso V.,De Placido S.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference52 articles.

1. Triple-negative breast cancer – current status and future directions;Gluz;Ann Oncol,2009

2. Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications;Sørlie;PNAS,2001

3. Pharmacotherapy of triple-negative breast cancer;Arslan;Expert Opin Pharmacother,2009

4. Triple-negative breast cancer: Novel therapies and new directions;Pal;Maturitas,2009

5. Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience;Aksoy;Ann Oncol,2007

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and biological evaluation of a novel PAK1 degrader for the treatment of triple negative breast cancer;Bioorganic & Medicinal Chemistry;2024-10

2. MOLECULAR TARGETS AS POTENTIAL PI3Kα INHIBITORS AGAINST AGGRESSIVE METASTATIC DUCTAL AND LOBULAR CARCINOMA;International Journal of Applied Pharmaceutics;2024-09-07

3. A Microfluidic 3D‐Tumor‐Spheroid Model for the Evaluation of Targeted Therapies from Angiogenesis‐Related Cytokines at the Single Spheroid Level;Advanced Healthcare Materials;2024-08-09

4. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer;Nature Communications;2024-04-24

5. Identification of immune-related prognostic biomarkers in triple-negative breast cancer;Translational Cancer Research;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3